MedPath

Developing Effective Response Inhibition Training for Symptom Relief in OCD and Trichotillomania

Not Applicable
Completed
Conditions
Obsessive Compulsive Disorder
Trichotillomania
Interventions
Behavioral: Placebo Control Training
Behavioral: Response inhibition training
Registration Number
NCT02059980
Lead Sponsor
University of Wisconsin, Milwaukee
Brief Summary

Obsessive-compulsive disorder (OCD) and its related disorders (e.g., trichotillomania) are characterized by the marked difficulty in inhibiting unwanted or inappropriate responses. There is compelling evidence that poor response inhibition is a core cognitive feature of OCD and its related disorders, but no effective intervention exists that directly attempts to address this problematic cognitive deficiency. This study will examine the feasibility and clinical utility of a computerized cognitive training program designed to improve response inhibition among individuals diagnosed with OCD or trichotillomania.This training program offers systematic practice of response inhibition in the form of a 40-level computer game. Individuals with these conditions will be randomized to either 8 sessions of (a) computerized response inhibition training (RIT) or (b) placebo computer training (PLT). We hypothesize that RIT will outperform PLT in improving response inhibition capabilities and reducing relevant clinical symptoms. In sum, this project is expected to generate important knowledge to guide the development of effective computer-based treatment approaches that may help reduce critical problems of existing treatments such as suboptimal patient retention and treatment under-utilization, thereby improving overall treatment response rates among individuals suffering from OCD and related conditions.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
45
Inclusion Criteria
  • Principal diagnosis of obsessive-compulsive disorder or trichotillomania
Exclusion Criteria
  • Current substance use problems
  • Current/Past Psychotic disorder, bipolar disorder, or schizophrenia
  • Attention deficit/hyperactivity disorder or tic disorder
  • Severe depressive symptoms
  • Current psychotherapy
  • Current suicidality
  • Estimated intellectual functioning < 80
  • Lack of response inhibition deficits on a stop-signal task

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Placebo Control TrainingPlacebo Control TrainingEight 45-minute sessions of computerized placebo control training over a 4 week period
Response inhibition trainingResponse inhibition trainingEight 45-minute sessions of computerized training on response inhibition over a 4 week period
Primary Outcome Measures
NameTimeMethod
Composite Score of Yale-Brown Obsessive-Compulsive Scale (Y-BOCS) and National Institute of Mental Health (NIMH)Baseline, Week 4, and Week 8

This is a clinician-administered rating scale of OCD symptom severity, most widely used in treatment outcome research for OCD, and a clinician-administered rating scale of hair pulling symptoms, widely used in clinical trial research for trichotillomania. Given the inclusion of two different diagnostic conditions, the primary outcome for the current study is the z score of the symptom rating severity obtained from the two rating scales, with higher values indicating greater symptom severity.

Stop Signal Reaction TimeBaseline, Week 4, and Week 8

Stop Signal Reaction Time (SSRT; time taken to complete the inhibitory process) is estimated using the tracking algorithm on the computerized stop-signal task, which adjusts the stop signal delay automatically (by 50ms) to maintain the rate of successful inhibition on stop-signal trials at 50%.

Secondary Outcome Measures
NameTimeMethod
Commission Errors on the Go/No-go Task.Baseline, Week 4, and Week 8

The number of commission errors on the go/no-go task is a commonly used measure of response inhibition. In this task, participants are asked to withhold their responses on no-go trials. If they fail to withhold their response in a no-go trial (i.e., pressing the response key to the no-go signal), this response counts toward the total number of commission errors. Therefore, a greater number of commission errors on this task reflects a greater level of inhibitory control deficit.

Clinical Global Impression Severity and ImprovementBaseline, Week 4, and Week 8

The Clinical Global Impression Severity and Improvement (CGI) is a clinician-administered rating scale widely used to assess the overall severity of the target condition in treatment outcome research. The CGI is assessed on a 7-point scale, with the severity scale from 1 (Normal, not at all ill) through to 7 (Among the most severely ill patients). Thus, the higher CGI severity rating score indicate a greater level of overall illness.

Trial Locations

Locations (1)

Psychology Clinic, University of Wisconsin-Milwaukee

🇺🇸

Milwaukee, Wisconsin, United States

© Copyright 2025. All Rights Reserved by MedPath